2.86512.52% ( -0.410 )
Delay Closed: Nov 16, 16:08:11Overview
IMMUNEONCO-B (1541)
ImmuneOnco Biopharmaceuticals (Shanghai) Inc., a biotechnology company, engages in the research and development of immuno-oncology therapies in China and the Un...
- Open
- 3.180
- High
- 3.180
- Low
- 2.850
- Prev. Close
- 3.275
- Volume
- 379.20K
- Turnover
- 1.13M
- Avg Price
- 2.989
- Bid/Ask Ratio
- 80.00%
- Amplitude
- 10.08%
- 52wk High
- 8.170
- Volume Ratio
- 0.83
- Turnover Ratio
- 0.09%
- 52wk Low
- 2.440
- HK Mkt Cap
- 1.20B
- Market CapHKD
- 1.23B
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -0.618
- EPSDynamic
- -0.881
- EPSStatic
- --
- BVPS
- 1.68
- P/B
- 1.71
- HK Shares
- 417.91M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 428.94M
- Min lot size
- 200
- Currency
- HKD
IMMUNEONCO-B Analyst Rating
View moreForecast & Rating
Jul 10, 2026Price forecast
HK$6.28119.22%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
News
PUBT · ImmuneOnco Discloses Share Buyback in Next-Day HKEX Filing
Market Movers · ImmuneOnco tumbles 12%
Weekly Review · Weekly Recap | IMMUNEONCO-B +18.23%, IMM0306 data powers rebound
Market Movers · ImmuneOnco climbs 7% on IMM0306 SLE trial data
Market Movers · ImmuneOnco surges 12% as IMM0306 SLE data shows 90.9% response rate
Market Movers · ImmuneOnco falls 9% in Hong Kong trading
